CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

A red quarter of a circle with the words 'The Quarter Mark' beside it. A year-long series looking back on the most significant moments of the past 25 years, how they changed our world, and how they ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

Being the only Neanderthal raised in a 21st-century world of humans would likely be lonely and isolating, possibly like the ...

John L. Hennessy is President Emeritus of Stanford University as well as the James F. and Mary Lynn Gibbons Professor of ...

Explore the future technologies transforming industries, from AI advancements to breakthroughs in renewable energy.

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...